MULTI MEMORY EXPRESS ZERTIFIKAT - LONZA GROUP/FRESENIUS MEDICAL CARE/CARL ZEISS MEDITEC Stock

Certificat

DE000UBS3SS9

Real-time Boerse Frankfurt Warrants 01:41:48 2024-07-11 pm EDT
92.47 EUR -0.82% Intraday chart for MULTI MEMORY EXPRESS ZERTIFIKAT - LONZA GROUP/FRESENIUS MEDICAL CARE/CARL ZEISS MEDITEC
Current month+1.72%
1 month-4.94%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-11 92.47 -0.82%
24-07-10 93.23 +2.04%
24-07-09 91.37 -0.86%
24-07-08 92.16 -0.12%
24-07-05 92.27 +0.26%

Real-time Boerse Frankfurt Warrants

Last update July 11, 2024 at 01:41 pm EDT

More quotes

Static data

Product typeOther Certificates
Buy / SellCALL
Underlying LONZA GROUP AG
Issuer UBS
WKN UBS3SS
ISINDE000UBS3SS9
Date issued 2024-06-07
Strike 515.2 CHF
Maturity 2025-11-24 (501 Days)
Parity 0.52 : 1
Emission price 99
Emission volume N/A
Settlement both
Currency EUR

Technical Indicators

Highest since issue 98.54
Lowest since issue 89.97
Spread 10
Spread %1.07%

Company Profile

Lonza Group AG is one of the world leaders of the development, production and marketing of chemical products. Net sales break down by family of products and services as follows: - bio-pharmaceuticals (55.4%): exclusive syntheses, microbiological fermentation products , mammalian cell cultures, etc.; - capsules and dosing solutions for biopharmaceuticals, drugs and nutrition products (17.3%). In addition, the group offers nutritional ingredients; - small molecule drug substances (13.4%); - technologies and platforms for manufacturing processes and production of cell and gene therapies (10.4%); - other (3.5%). Net sales are distributed geographically as follows: Switzerland (17.4%), Europe (31.7%), the United States (31.8%), the Americas (3.2%), Japan (8.1%), Asia (7.5%) and other (0.3%).
Sector
-
More about the company

Ratings for Lonza Group AG

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Lonza Group AG

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
510 CHF
Average target price
586 CHF
Spread / Average Target
+14.90%
Consensus